Advertisement

Topics

Companies Related to "Arquer Diagnostics awarded funding under Innovate Biocatalyst programme" [Most Relevant Company Matches] RSS

11:25 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Arquer Diagnostics awarded funding under Innovate Biocatalyst programme" found in our extensive corporate database of over 50,000 company records.

Showing "Arquer Diagnostics awarded funding under Innovate Biocatalyst programme" Companies 1–25 of 1,900+

Extremely Relevant

BioCatalyst International

BioCatalyst is a group of experienced business and scientific entrepreneurs who are focused on transitioning a scientifically validated product to an accepted product in the marketplace. BioCatalyst is an operating team, as opposed to an investment firm. We provide the seed capital, experience and market knowledge to make this happen, at which point we raise expanded venture or corporate funding...


Relevant

Measurements for Biotechnology

The Measurements for Biotechnology (MfB) Programme is one of a portfolio of programmes supporting the development of the UK’s National Measurement System (NMS).The Programme has been commissioned by DTI's National Measurement System Directorate following wide consultation on requirements. The Programme consists of a series of projects, awarded by competitive tender, which will deliver and d...

Amura Holdings Ltd

Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcore™, the bicyclic core molecular scaffold chemistry and the computational screening and design platform, ProtoDiscovery™. Amura has four NCE discovery programmes based on AMcore™:An Osteoporosis programme based on cathepsin K inhibitors, A Psoriasis programme based on a cathepsin S inhibit...


UF Innovate | Sid Martin Biotech

UF Innovate | Sid Martin Biotech is the leading biotechnology incubator headquartered at the University of Florida in Alachua, Florida at Progress Park. Sid Martin has been honored with national and international awards for incubator excellence and achievements in technology commercialization, funding access, job creation and technology-based economic deve...

Alaska Food Diagnostics Ltd

Alaska Food Diagnostics Ltd is a unique joint venture, established in 2000, between the Defence Science and Technology Laboratory (Dstl), the UK Government’s centre of scientific excellence based at Porton Down - and private investors. Alaska Food Diagnostics Ltd benefits from 10 years of government funded development of it’s patented fastrAK™ technology. Alaska Food Diagnostics Ltd has asse...

Amura Therapeutics Ltd

Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcore™, the bicyclic core molecular scaffold chemistry and the computational screening and design platform, ProtoDiscovery™. Amura has four NCE discovery programmes based on AMcore™: An Osteoporosis programme based on cathepsin K inhibitors A Psoriasis programme based on a cathepsin S inhibit...

Randox Laboratories Ltd.

Randox Laboratories was founded in 1982 by Dr Peter FitzGerald. Since its inception in 1982, Randox have developed some of the most exciting and revolutionary technology in the field of medical diagnostics. Randox awards Dr Peter FitzGerald wins Ernst & Young Entrepreneur of the Year 2004 A global recognition programme, created to identify, support and reward entrepreneurs across all sectors Rando...

Innovation Catalyst Ltd

This year, we're launching an exciting new programme to help universities turn their latent intellectual property potential into the reality of market-ready companies.To promote and explain this programme, we're completely re-writing our web site. In the meantime, if you'd like more information on turning your ideas' potential into reality

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the potent immune-regulating properties of novel bacterial isolates derived from the healthy human gut. We have completed a research-intensive innovative programme spanning several years investigating the i...

Business Boffins Ltd

Business Boffins was established in 1999 and provides mentoring and support to new and young businesses. Working closely with the South East England Development Agency and Oxford Brookes University Business School, Business Boffins has developed a unique three-year business mentoring programme suitable for all small businesses. The programme draws upon knowledge from the Business School backed wit...

UCLA School of Nursing

The UCLA School of Nursing is redefining nursing through the pursuit of uncompromised excellence in research, education, practice, policy and patient advocacy. Rated among the nation’s top nursing schools by U.S. News & World Report, the school also is ranked No. 7 in nursing research funded by the National Institutes of Health and No. 1 in NIH ...

Sencel Bioinformatics AS

Sencel Bioinformatics was founded in June 2001 by Erling Seeberg and Torbjørn Rognes.The company's vision is to provide superior software tools to aid in genetic and genomic research and diagnostics. The name of the company stems from the mission to make sense of genetic data at an accelerated speed.Sencel's products are based on several years of scientific research at Rikshospitalet-Radiumhospit...

Omega Diagnostics Group PLC

Founded in 1987 by the current CEO Andrew Shepherd, Omega Diagnostics Group PLC is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease. With its global headquarters based in Scotland, the group has subsidiaries in Littleport (Cambridge, UK),...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices throughout the world. Formerly known as Genzyme Diagnostics, Sekisui Diagnostics has over 30 years of experience developing, manufacturing and commercializing a variety of unique ...

PharmaCluster

PharmaCluster Finland is a project of the national Centre of Expertise Programme under the Ministry of the Interior, running to 2006. The project was set up in 1998 to develop a pharmaceutical network. Since 1999 coordination of PharmaCluster has been part of the South-West Finland Centre of Expertise programme under the responsibility of Turku Science Park Ltd. and Turku Bio Valley Ltd. The Unive...

Ziarco

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting inflammatory and allergic diseases. The company’s product pipeline includes ZPL-3893787, an H4 receptor antagonist that has completed a Phase 1 multiple ascending dose study. A second clinical-stage, programme targets inflammatory disorders by inhibiting cyto...

International Council for Science (ICSU

Founded in 1931 to promote international scientific activity in the different branches of science and its application for the benefit of humanity, the International Council for Science (ICSU) is one of the oldest non-governmental organizations in the world. It represents the evolution and expansion of two earlier bodies known as the International Association of Academies (IAA; 1899-1914) and the I...

HepatoSys - systems biologycompetence network of hepatocytes
AG

From January 2004 on, the BMBF funded an innovative and interdisciplinary research initiative in systems biology to complement acitvities in the German Federal Government´s Programme "Biotechnology - using and shaping its opportunities".The funding priority HepatoSys will focus on a quantitative understanding of complex and dynamic cellular processes in endocytosis, detoxification and regeneratio...

Xenobiotic Detection Systems, Inc.

Xenobiotic Detection Systems (XDS) was started in 1995 by Drs. George C. Clark and Michael S. Denison. In 1997 XDS received major Research and Development funding from the National Institutes of Health. In 1998 XDS was awarded a patent for its proprietary CALUX® (Chemically-Activated LUciferase gene eXpression cell bioassay system) assay for dioixn-like chemicals.Further improvements have been ma...

Innovate North State

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac and critical care diagnostics.Innotrac Diagnostics has proven expertise in immunoassay system development (chemistry, hardware and software).Innotrac is a proven supplier of contract manufacturing ser...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology investigates biomarkers at the structural level as opposed to overall concentration, giving better insights as to its cellular origin. Its pipeline of high performance, non-invasive ca...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs. The Presage ST2 Assay has been CE Marked and cleared by the US FDA. Critical Diagnostics has exclusive worldwide rights to ST2 for the diagnosis and prognosis of cardiovascular ...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (www.erbadiagnostics.com), headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases, through its legacy...

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology. Fujirebio Diagnostics is one of the group companies of Miraca Holdings, Inc., ...


More From BioPortfolio on "Arquer Diagnostics awarded funding under Innovate Biocatalyst programme"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks